Results 111 to 120 of about 9,958 (268)

A long, strange trip: Ketamine treatment in psychiatry. [PDF]

J Psychopharmacol
Nutt DJ, Morgan C, Erritzoe D, Greenway KT, Young AH.   +4 more
europepmc   +1 more source

Serial maternal filicide as evidence of Munchausen syndrome by proxy

Journal of Forensic Sciences, EarlyView.
Abstract Munchausen Syndrome by Proxy (MSBP), or Fabricated or Induced Illness (FII), is a form of physical and emotional child abuse and maltreatment that remains frequently under‐detected due to a significant lack of clinical awareness. This case report aims to highlight the challenges of diagnosing MSBP, its impact on victims, and the ethical ...
Ahlem Mtiraoui, Oussama Ajmi, Asma Allaya, Amel Braham, Jaafar Nakhli   +4 more
wiley   +1 more source

Therapeutic Factors in In-patient Psychotherapy Groups [PDF]

British Journal of Psychiatry, 1988
G S, Whalan, G L, Mushet
openaire   +2 more sources

Influence of Sex and Diagnosis on Clinical Variables and Neurocognitive Performance in Severe Mental Illness. Results From the PsyCourse Study

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Bipolar disorder (BD) and schizophrenia (SZ) are serious mental illnesses (SMI) with overlapping symptoms but distinct differences in onset and course. Sex differences are an area of growing interest in SMI. This study aims to examine potential interactions between sex and diagnosis across a broad range of variables, to compare ...
Maria Serra‐Navarro, Maria Heilbronner, Brisa Solé, Roger Borràs, Anabel Martinez‐Arán, Kristina Adorjan, Alba Navarro‐Flores, Mojtaba Oraki Kohshour, Daniela Reich‐Erkelenz, Eva C. Schulte, Fanny Senner, Ion‐George Anghelescu, Volker Arolt, Bernhard T. Baune, Udo Dannlowski, Detlef E. Dietrich, Andreas J. Fallgatter, Christian Figge, Markus Jäger, Georg Juckel, Carsten Konrad, Jens Reimer, Eva Z. Reininghaus, Max Schmauß, Andrea Schmitt, Carsten Spitzer, Jens Wiltfang, Jörg Zimmermann, Sergi Papiol, Urs Heilbronner, Peter Falkai, Thomas G. Schulze, Eduard Vieta, Carla Torrent, Monika Budde, Silvia Amoretti   +35 more
wiley   +1 more source

Innovations to improve outcomes and uptake of psychotherapies for mental disorders: a state-of-the-art review. [PDF]

World Psychiatry
Cuijpers P, Harrer M, Furukawa TA.
europepmc   +1 more source

Predicting Response to Pro‐Cognitive Interventions in Mood Disorders: A Systematic Review by the International Society for Bipolar Disorders Targeting Cognition Task Force

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Major depressive disorder (MDD) and bipolar disorder (BD) are often associated with persistent cognitive deficits that impair psychosocial functioning. While pro‐cognitive interventions show promise, trial findings are inconsistent, potentially due to baseline factors influencing treatment response.
Dimosthenis Tsapekos, Michail Kalfas, Johanna M. Schandorff, Caterina del Mar Bonnin, Christopher R. Bowie, Vicent Balanzá‐Martínez, Katherine E. Burdick, Andre F. Carvalho, Annemieke Dols, Katie Douglas, Peter Gallagher, Gregor Hasler, Lars V. Kessing, Hanne L. Kjærstad, Beny Lafer, Kathryn E. Lewandowski, Carlos López‐Jaramillo, Anabel Martinez‐Aran, Roger S. McIntyre, Richard J. Porter, Scot E. Purdon, Ayal Schaffer, Paul R. A. Stokes, Tomiki Sumiyoshi, Ivan J. Torres, Tamsyn E. Van Rheenen, Lakshmi N. Yatham, Jeff Zarp, Allan H. Young, Eduard Vieta, Kamilla W. Miskowiak   +30 more
wiley   +1 more source

From implication to elaboration: a group-based experience in clinical sociology

Forum for Group Psychotherapies and Processes
The objective of this article was to discuss the subjective and group effects of participation in the socio clinical intervention Group of Implication and Research (GIR), based on the analysis of implications. Through the authors’ participation in a Life
Luciana Othenio Carreteiro, Valeria Quiroga Vinhas   +1 more
doaj  

The collective lie in ketamine therapy: a call to realign clinical practice with neurobiology. [PDF]

Front Psychiatry
Miller C, Lopes B, McCurdy A.
europepmc   +1 more source

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens, Dahbia Belahda, Carine Graux, Noe Igounenc, Chris Serrand, Paul Rochefort, Thibault Mura, Felix Sergent   +7 more
wiley   +1 more source

Placebo in Functional Neurological Disorders: Promise and Controversy. [PDF]

Healthcare (Basel)
Szejko N, Abusrair A, Pasierski T, Schmitt S, Cramer C, Pietrzykowski T, Dunalska A, Saramak K, Śmiłowska K, Serranova T, Müller-Vahl KR.   +10 more
europepmc   +1 more source